Edap Tms SA (NASDAQ:EDAP) was the recipient of a significant growth in short interest during the month of September. As of September 30th, there was short interest totalling 51,900 shares, a growth of 30.1% from the August 30th total of 39,900 shares. Based on an average daily volume of 191,400 shares, the short-interest ratio is presently 0.3 days. Currently, 0.2% of the company’s stock are sold short.
Several research analysts recently commented on the company. HC Wainwright set a $7.00 price target on Edap Tms and gave the company a “buy” rating in a research report on Friday, August 30th. ValuEngine cut Edap Tms from a “buy” rating to a “hold” rating in a research report on Wednesday, October 2nd. Zacks Investment Research raised Edap Tms from a “hold” rating to a “strong-buy” rating and set a $4.25 price target for the company in a research report on Friday, September 6th. Finally, TheStreet cut Edap Tms from a “b-” rating to a “d+” rating in a research report on Monday, June 17th.
Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Hilton Capital Management LLC acquired a new stake in shares of Edap Tms in the first quarter valued at approximately $75,000. JPMorgan Chase & Co. acquired a new stake in shares of Edap Tms in the second quarter valued at approximately $282,000. Susquehanna International Group LLP lifted its position in shares of Edap Tms by 762.9% in the second quarter. Susquehanna International Group LLP now owns 205,178 shares of the medical equipment provider’s stock valued at $556,000 after buying an additional 181,401 shares during the last quarter. Acadian Asset Management LLC acquired a new stake in shares of Edap Tms in the second quarter valued at approximately $607,000. Finally, Morgan Stanley lifted its position in shares of Edap Tms by 222.7% in the second quarter. Morgan Stanley now owns 267,408 shares of the medical equipment provider’s stock valued at $722,000 after buying an additional 184,539 shares during the last quarter. 13.24% of the stock is owned by institutional investors.
NASDAQ EDAP traded up $0.04 during trading hours on Friday, hitting $4.62. 188,101 shares of the company traded hands, compared to its average volume of 213,121. Edap Tms has a twelve month low of $1.35 and a twelve month high of $5.42. The stock has a market capitalization of $133.98 million, a price-to-earnings ratio of 231.00 and a beta of 1.88. The business’s 50-day moving average is $3.98 and its 200-day moving average is $3.59.
Edap Tms (NASDAQ:EDAP) last released its quarterly earnings data on Wednesday, August 28th. The medical equipment provider reported $0.05 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.01 by $0.04. Edap Tms had a return on equity of 23.31% and a net margin of 4.57%. The company had revenue of $14.04 million during the quarter, compared to analysts’ expectations of $11.92 million. As a group, research analysts forecast that Edap Tms will post 0.18 EPS for the current fiscal year.
About Edap Tms
EDAP TMS SA, together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally-invasive medical devices for the treatment of urological diseases worldwide. The company operates in two divisions: High Intensity Focused Ultrasound (HIFU), and Urology Devices and Services (UDS).
Further Reading: Is it better to buy a fund with a higher or lower NAV?
Receive News & Ratings for Edap Tms Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Edap Tms and related companies with MarketBeat.com's FREE daily email newsletter.